Heparan sulfate is increasingly recognized as a key factor in infection by the SARS-CoV-2 virus, which is the cause of the current COVID-19 coronavirus pandemic

The DimAb™ development platform is different from traditional hybridoma fusion technologies in that it can directly isolate IgG genes from B cells of immunized animals

Perfect for use in a wide range of different antibody detection methods, these antigens are customizable and available in bulk

New AMSBIO product range includes a kit to facilitate rapid and efficient differentiation of human iPS or ES cells into skeletal muscle cells in just seven days

AMSBIO announces StemFit® for MSC, an optimized medium for expansion and maintenance of Mesenchymal Stem Cells

STEM-CELLBANKER® and HSC-BANKER® provide optimal freezing solutions for clinical applications

AMSBIO announce a new service designed to provide high-content cytometry data on cells and tissues enabling the automated analysis of fluorescent biomarkers on living cells or long-term stored biobanked cells and tissues

The unique chemically defined composition of StemFit® for Differentiation minimizes lot-to-lot variation, enabling highly consistent cell differentiation

The Exosome Isolation & Quantification Service from AMSBIO provides reliable and reproducible isolation of exosomes from almost any biofluid

New products can capture the anti-SARS-CoV-2 antibody or ACE2 protein from cell or serum sample